Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, R.
Right arrow Articles by Kostner, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, R.
Right arrow Articles by Kostner, G. M.

(Stroke. 1997;28:951-956.)
© 1997 American Heart Association, Inc.


Articles

Apolipoprotein E Polymorphism and Silent Microangiopathy-Related Cerebral Damage

Results of the Austrian Stroke Prevention Study

R. Schmidt, MD; H. Schmidt, MD; F. Fazekas, MD; M. Schumacher, MD; K. Niederkorn, MD; P. Kapeller, MD; V. Weinrauch, MD; G. M. Kostner, PhD

From the Departments of Neurology (R.S., F.F., K.N., P.K.) and Internal Medicine (M.S., V.W.), the Institute of Medical Biochemistry (H.S., G.M.K.), and the MRI Center (R.S., F.F., P.K.), Karl-Franzens University Graz, Austria.

Correspondence to Reinhold Schmidt, MD, Department of Neurology, Karl-Franzens University Graz, Auenbruggerplatz 22, A-8036 Graz, Austria. E-mail reinhold.schmidt{at}kfunigraz.ac.at

Background and Purpose Microangiopathy-related cerebral damage (MARCD) includes white matter abnormalities and lacunar infarctions and represents a common MRI observation in subjects above 50 years of age. The risk factors of such brain abnormalities are not fully determined. The goal of this study was to determine whether the genetic heterogeneity of apolipoprotein E (apoE) contributes to the occurrence of MARCD.

Methods Brain MRI (1.5 T) was performed in 280 individuals (ages 50 to 75 years) without neuropsychiatric disease randomly selected from the official register of residents of the city of Graz, Austria. All study participants underwent apoE genotyping, carotid Doppler sonography, electrocardiography, echocardiography, and a complete blood chemistry panel. MARCD was defined as evidence of early confluent and confluent white matter hyperintensities or lacunes. Carotid atherosclerosis was graded on a five-point scale ranging from not present (0) to complete occlusion (5).

Results MARCD occurred in 61 individuals (21%). The distribution of apoE genotypes differed significantly between subjects with and without MARCD (P=.036). Subjects with such findings more commonly had the {epsilon}2/{epsilon}3 genotype (24.6% versus 10%) at similar frequencies of genotypes containing the {epsilon}4 allele. The {epsilon}2/{epsilon}3 genotype was associated with lower levels of total cholesterol (P=.0009), LDL cholesterol (P=.00001), and apolipoprotein B (P=.00001). Also, there was a nonsignificant trend toward less cardiac disease. Other major vascular risk factors and carotid abnormalities were similar among the various genotypes. Multiple logistic regression analysis created a model of significant MARCD predictors, including age (odds ratio [OR], 1.1 per year), hypertension (OR, 3.4), and the apoE {epsilon}2/{epsilon}3 genotype (OR, 3.0).

Conclusions These data suggest an association between the apoE {epsilon}2/{epsilon}3 genotype and MARCD despite favorable effects on the lipid profile and cardiac disease.


Key Words: apolipoproteins • lacunar infarction • magnetic resonance imaging • stroke prevention • white matter




This article has been cited by other articles:


Home page
StrokeHome page
O. Godin, C. Tzourio, P. Maillard, A. Alperovitch, B. Mazoyer, and C. Dufouil
Apolipoprotein E Genotype Is Related to Progression of White Matter Lesion Load
Stroke, October 1, 2009; 40(10): 3186 - 3190.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Ay, E. M. Arsava, J. Rosand, K. L. Furie, A. B. Singhal, P. W. Schaefer, O. Wu, R. G. Gonzalez, W. J. Koroshetz, and A. G. Sorensen
Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke
Stroke, May 1, 2008; 39(5): 1409 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Zivadinov, B. Weinstock-Guttman, R. Benedict, M. Tamano-Blanco, S. Hussein, N. Abdelrahman, J. Durfee, and M. Ramanathan
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor
Hum. Mol. Genet., November 15, 2007; 16(22): 2659 - 2668.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
G. Liew, A. Shankar, J. J. Wang, R. Klein, M. S. Bray, D. J. Couper, A. R. Sharrett, and T. Y. Wong
Apolipoprotein E Gene Polymorphisms and Retinal Vascular Signs: The Atherosclerosis Risk in Communities (ARIC) Study
Arch Ophthalmol, June 1, 2007; 125(6): 813 - 818.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Lemmens, A. Gorner, M. Schrooten, and V. Thijs
Association of Apolipoprotein E {epsilon}2 With White Matter Disease but Not With Microbleeds
Stroke, April 1, 2007; 38(4): 1185 - 1188.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Debette, J.-C. Lambert, J. Gariepy, N. Fievet, C. Tzourio, J.-F. Dartigues, K. Ritchie, A.-M. Dupuy, A. Alperovitch, P. Ducimetiere, et al.
New Insight Into the Association of Apolipoprotein E Genetic Variants With Carotid Plaques and Intima-Media Thickness
Stroke, December 1, 2006; 37(12): 2917 - 2923.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. M. Burwick, P. P. Ramsay, J. L. Haines, S. L. Hauser, J. R. Oksenberg, M. A. Pericak-Vance, S. Schmidt, A. Compston, S. Sawcer, R. Cittadella, et al.
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers
Neurology, May 9, 2006; 66(9): 1373 - 1383.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Enzinger, F. Fazekas, P. M. Matthews, S. Ropele, H. Schmidt, S. Smith, and R. Schmidt
Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
Neurology, May 24, 2005; 64(10): 1704 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. A. Manolio, E. Boerwinkle, C. J. O'Donnell, and A. F. Wilson
Genetics of Ultrasonographic Carotid Atherosclerosis
Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1567 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
H.-K. Kuo and L. A. Lipsitz
Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link?
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M818 - M826.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. T. Turner, C. R. Jack, M. Fornage, T. H. Mosley, E. Boerwinkle, and M. de Andrade
Heritability of Leukoaraiosis in Hypertensive Sibships
Hypertension, February 1, 2004; 43(2): 483 - 487.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hassan and H. S. Markus
Genetics and ischaemic stroke
Brain, September 1, 2000; 123(9): 1784 - 1812.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Schiefermeier, H. Kollegger, C. Madl, C. Schwarz, M. Holzer, J. Kofler, and F. Sterz
Apolipoprotein E Polymorphism : Survival and Neurological Outcome After Cardiopulmonary Resuscitation
Stroke, September 1, 2000; 31(9): 2068 - 2073.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori
Effect of the Apolipoprotein E {epsilon}4 Allele on White Matter Hyperintensities in Dementia
Stroke, June 1, 2000; 31(6): 1263 - 1268.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Schiefermeier, H. Kollegger, C. Madl, C. Polli, W. Oder, H.-J. Kuhn, F. Berr, and P. Ferenci
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease
Brain, March 1, 2000; 123(3): 585 - 590.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Zhu, L. Fratiglioni, Z. Guo, H. Basun, E. H. Corder, B. Winblad, and M. Viitanen
Incidence of Dementia in Relation to Stroke and the Apolipoprotein E {epsilon}4 Allele in the Very Old : Findings From a Population-Based Longitudinal Study
Stroke, January 1, 2000; 31(1): 53 - 60.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. DeCarli, T. Reed, B. L. Miller, P. A. Wolf, G. E. Swan, and D. Carmelli
Impact of Apolipoprotein E {epsilon}4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study
Stroke, August 1, 1999; 30(8): 1548 - 1553.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Schmidt, R. Schmidt, K. Niederkorn, A. Gradert, M. Schumacher, N. Watzinger, H.-P. Hartung, and G. M. Kostner
Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study
Stroke, October 1, 1998; 29(10): 2043 - 2048.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. T. Longstreth Jr, C. Bernick, T. A. Manolio, N. Bryan, C. A. Jungreis, T. R. Price, and for the Cardiovascular Health Study Collaborative
Lacunar Infarcts Defined by Magnetic Resonance Imaging of 3660 Elderly People: The Cardiovascular Health Study
Arch Neurol, September 1, 1998; 55(9): 1217 - 1225.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Schmidt, R. Schmidt, K. Niederkorn, S. Horner, P. Becsagh, B. Reinhart, M. Schumacher, V. Weinrauch, and G. M. Kostner
ß-Fibrinogen Gene Polymorphism (C148->T) Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study
Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 487 - 492.
[Abstract] [Full Text] [PDF]